188 related articles for article (PubMed ID: 25017386)
1. Isobolographic analysis of the opioid-opioid interactions in a tonic and a phasic mouse model of induced nociceptive pain.
Miranda HF; Noriega V; Zanetta P; Prieto JC; Prieto-Rayo JC; Aranda N; Sierralta F
J Biomed Sci; 2014 Jul; 21(1):62. PubMed ID: 25017386
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the opioid-opioid combinations according to the nociceptive stimulus in mice.
Romero A; Miranda HF; Puig MM
Pharmacol Res; 2010 Jun; 61(6):511-8. PubMed ID: 20206265
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness comparisons of G-protein biased and unbiased mu opioid receptor ligands in warm water tail-withdrawal and drug discrimination in male and female rats.
Schwienteck KL; Faunce KE; Rice KC; Obeng S; Zhang Y; Blough BE; Grim TW; Negus SS; Banks ML
Neuropharmacology; 2019 May; 150():200-209. PubMed ID: 30660628
[TBL] [Abstract][Full Text] [Related]
4. Antinociceptive effects of morphine, fentanyl, tramadol and their combination, in morphine-tolerant mice.
Romero A; Miranda HF; Puig MM
Pharmacol Biochem Behav; 2010 Dec; 97(2):363-9. PubMed ID: 20843476
[TBL] [Abstract][Full Text] [Related]
5. Antinociceptive effects of two deltorphins analogs in the tail-immersion test in rats.
Kotlinska JH; Gibula-Bruzda E; Witkowska E; Chung NN; Schiller PW; Izdebski J
Peptides; 2013 Jan; 39():103-10. PubMed ID: 23183627
[TBL] [Abstract][Full Text] [Related]
6. Synergistic and additive interactions of the cannabinoid agonist CP55,940 with mu opioid receptor and alpha2-adrenoceptor agonists in acute pain models in mice.
Tham SM; Angus JA; Tudor EM; Wright CE
Br J Pharmacol; 2005 Mar; 144(6):875-84. PubMed ID: 15778704
[TBL] [Abstract][Full Text] [Related]
7. Possible involvement of mu1-opioid receptors in the fentanyl- or morphine-induced antinociception at supraspinal and spinal sites.
Narita M; Imai S; Itou Y; Yajima Y; Suzuki T
Life Sci; 2002 Apr; 70(20):2341-54. PubMed ID: 12150199
[TBL] [Abstract][Full Text] [Related]
8. Effects of N-methyl-D-aspartate receptor antagonists on acute morphine-induced and l-methadone-induced antinociception in mice.
Fischer BD; Carrigan KA; Dykstra LA
J Pain; 2005 Jul; 6(7):425-33. PubMed ID: 15993820
[TBL] [Abstract][Full Text] [Related]
9. Isobolographic analysis of interaction between cyclooxygenase inhibitors and tramadol in acetic acid-induced writhing in mice.
Satyanarayana PS; Jain NK; Singh A; Kulkarni SK
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):641-9. PubMed ID: 15276689
[TBL] [Abstract][Full Text] [Related]
10. Synergistic antinociceptive actions and tolerance development produced by morphine-fentanyl coadministration: correlation with μ-opioid receptor internalization.
Silva-Moreno A; Gonzalez-Espinosa C; León-Olea M; Cruz SL
Eur J Pharmacol; 2012 Jan; 674(2-3):239-47. PubMed ID: 22079772
[TBL] [Abstract][Full Text] [Related]
11. Discriminative stimulus effects of two doses of fentanyl in rats: pharmacological selectivity and effect of training dose on agonist and antagonist effects of mu opioids.
Zhang L; Walker EA; Sutherland J; Young AM
Psychopharmacology (Berl); 2000 Feb; 148(2):136-45. PubMed ID: 10663428
[TBL] [Abstract][Full Text] [Related]
12. Dextromethorphan and ketamine potentiate the antinociceptive effects of mu- but not delta- or kappa-opioid agonists in a mouse model of acute pain.
Baker AK; Hoffmann VL; Meert TF
Pharmacol Biochem Behav; 2002 Dec; 74(1):73-86. PubMed ID: 12376154
[TBL] [Abstract][Full Text] [Related]
13. Interactions of NMDA antagonists and an alpha 2 agonist with mu, delta and kappa opioids in an acute nociception assay.
Baker AK; Hoffmann VL; Meert TF
Acta Anaesthesiol Belg; 2002; 53(3):203-12. PubMed ID: 12461830
[TBL] [Abstract][Full Text] [Related]
14. Synergism between fentanyl and tramadol in tonic inflammatory pain: the orofacial formalin test.
Miranda HF; Noriega V; Zepeda RJ; Sierralta F; Prieto JC
Inflammation; 2012 Jun; 35(3):1132-7. PubMed ID: 22198345
[TBL] [Abstract][Full Text] [Related]
15. Identification of opioid receptor subtypes in antinociceptive actions of supraspinally-administered mitragynine in mice.
Thongpradichote S; Matsumoto K; Tohda M; Takayama H; Aimi N; Sakai S; Watanabe H
Life Sci; 1998; 62(16):1371-8. PubMed ID: 9585164
[TBL] [Abstract][Full Text] [Related]
16. Lack of effect of naltrindole on the spinal synergism of morphine and non-steroidal anti-inflammatory drugs (NSAIDS).
Miranda HF; Pinardi G
J Physiol Pharmacol; 2009 Jun; 60(2):71-6. PubMed ID: 19617648
[TBL] [Abstract][Full Text] [Related]
17. Systemic synergism between codeine and morphine in three pain models in mice.
Miranda HF; Noriega V; Zepeda RJ; Sierralta F; Prieto JC
Pharmacol Rep; 2013; 65(1):80-8. PubMed ID: 23563026
[TBL] [Abstract][Full Text] [Related]
18. The role of beta-arrestin2 in the severity of antinociceptive tolerance and physical dependence induced by different opioid pain therapeutics.
Raehal KM; Bohn LM
Neuropharmacology; 2011 Jan; 60(1):58-65. PubMed ID: 20713067
[TBL] [Abstract][Full Text] [Related]
19. Characterization of opioidergic mechanisms related to the anti-migraine effect of vagus nerve stimulation.
Hu B; Akerman S; Goadsby PJ
Neuropharmacology; 2021 Sep; 195():108375. PubMed ID: 33444636
[TBL] [Abstract][Full Text] [Related]
20. Enhancement mu opioid antinociception by oral delta9-tetrahydrocannabinol: dose-response analysis and receptor identification.
Cichewicz DL; Martin ZL; Smith FL; Welch SP
J Pharmacol Exp Ther; 1999 May; 289(2):859-67. PubMed ID: 10215664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
